Norbert Lowe News Today

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic pharmaceutical technology company, tod...

Redwood City, California to complement Eyenovia’s facility in Reno, Nevada as well as its contract manufacturer, Coastline International, to produce commercial supply of Mydcombi NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company, today announced that the company’s facility in Redwood City, California successfully completed FDA inspection for approval as a commercial manufacturing facility. The Redwood City facility will...

06.11.2023 - Company to host an investor conference call and webcast at 4:30pm EDTNEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) - Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company commercializing Mydcombi for mydriasis, preparing for regulatory ...

NEW YORK, Aug. 09, 2023 -- Eyenovia, Inc. , an ophthalmic technology company commercializing Mydcombi™ 1%/2.5% for mydriasis and developing the Optejet® device for use both in connection with...

Eyenovia is stepping up the capabilities of its facilities and taking advantage of the thriving innovation culture and expertise in Reno, Nevada, ...

FDA gave approval of their first drug on May 8th, 2023. The company is now finalizing its drug launch in the coming months. Click here to read more on EYEN stock.

30.03.2023 - Announced FDA acceptance of Mydcombi New Drug Application (NDA) and PDUFA action date of May 8, 2023 Announced positive results from Microline Phase 3 program as a potential treatment for presbyopia and received feedback from the FDA outlining a ...

23.11.2022 - NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) - Eyenovia, Inc. (Nasdaq: EYEN), a pre-commercial ophthalmic technology company developing the Optejet delivery system for use both in combination with its own drug-device therapeutic programs for ...

Entrepreneur-eye surgeon continues his family's legacy in the field of ophthalmology, as Eyenovia's new Chairman...

New internal manufacturing capabilities to complement existing contract manufacturing relationships...